Minnesota Proposes to Reduce Opioid Product Registration Fees Related to Hospitals
FDA Law
JUNE 28, 2021
Richardson — A recent proposed amendment to Minnesota’s Opiate Product Registration Fee appears intended to ensure continued availability of certain opiate products at hospitals. If enacted, Article 5, Section 6 of HF33 would provide for a reduction to the State’s opiate product registration fee.
Let's personalize your content